Your Health, We Care
Resmetirom was approved by the United States Food and Drug Administration(FDA) for the treatment of nonalcoholic steatohepatitis (NASH) on March 14,2024
This is the first FDA-approved treatment for NASH and marks an important milestone in the field.
